NexVita: The Future of Personalized Longevity
What We Do
NexVita is a digital-first longevity clinic that uses AI, genomics, and real-time biomarker tracking to create highly personalized health optimization protocols. Our mission is to redefine aging by empowering individuals to take control of their biological age, not just their calendar age.
The Problem
Modern medicine is reactive. People wait for symptoms before seeking help, and by then, chronic conditions may have already taken hold. Aging, though inevitable, is often accelerated by undiagnosed inflammation, poor lifestyle choices, and invisible metabolic markers.
Our Solution
NexVita blends continuous health monitoring, predictive algorithms, and longevity science to slow or even reverse the aging process. We offer:
- At-home biological testing kits
- Continuous glucose, sleep, and activity tracking via wearable integrations
- AI-generated, doctor-reviewed health optimization plans
- Monthly health coaching and biomarker interpretation
Our system evolves with your body, dynamically adjusting your protocol as your data changes.
Why Now
With the convergence of wearable tech, genomics, and cloud-based AI, we finally have the infrastructure to shift healthcare from treatment to prevention. The global longevity economy is projected to exceed $27 trillion by 2027, yet few companies are focused on personalized preventative care.
Business Model
NexVita operates on a subscription-based model, with tiered plans ranging from basic self-monitoring to full concierge medical guidance. Partnerships with wearable brands and nutraceutical companies further diversify revenue.
Market
Our initial target includes health-conscious professionals aged 30–55, tech-savvy early adopters, and wellness-oriented communities in the US and Europe. Over time, we’ll expand to emerging health-conscious demographics globally.
Traction
- Beta launched with 500 users showing a 17% average improvement in biological age markers over 3 months.
- Strategic partnerships with two major wearable tech companies.
- Waitlist of 2,000+ potential customers pre-launch.
The Team
Led by longevity researchers, AI engineers, and digital health veterans from Stanford, DeepMind, and One Medical.
Our Ask
We are raising a $3M seed round to scale our technology, expand clinical trials, and onboard our first 10,000 users.
NexVita is not just extending life. We're extending the quality of life.
